Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (Unaudited)

v3.21.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 310,111 $ 116,209,889 $ (118,789,000) $ (2,269,000)
Balance at beginning, shares at Dec. 31, 2019 310,111,536      
Common stock issued on exercise of warrants and options $ 1,215 59,785 61,000
Common stock issued on exercise of warrants and options, shares 1,215,000      
Common stock issued on conversion of notes payable $ 8,096 366,904 375,000
Common stock issued on conversion of notes payable, shares 8,094,707      
Warrants and beneficial conversion feature of issued convertible notes 212,000 212,000
Fair value of options and warrants issued as compensation 296,000 296,000
Common stock issued for cash in private sale of securities $ 1,667 23,333 25,000
Common stock issued for cash in private sale of securities, shares 1,666,667      
Net loss (2,043,000) (2,043,000)
Ending balance, value at Sep. 30, 2020 $ 321,089 117,167,911 (120,832,000) (3,343,000)
Balance at ending, shares at Sep. 30, 2020 321,087,910      
Beginning balance, value at Jun. 30, 2020 $ 319,422 117,061,578 (120,396,000) (3,015,000)
Balance at beginning, shares at Jun. 30, 2020 319,421,243      
Common stock issued on exercise of warrants and options
Common stock issued on conversion of notes payable
Warrants and beneficial conversion feature of issued convertible notes
Fair value of options and warrants issued as compensation 83,000 83,000
Common stock issued for cash in private sale of securities $ 1,667 23,333 25,000
Common stock issued for cash in private sale of securities, shares 1,666,667      
Net loss (436,000) (436,000)
Ending balance, value at Sep. 30, 2020 $ 321,089 117,167,911 (120,832,000) (3,343,000)
Balance at ending, shares at Sep. 30, 2020 321,087,910      
Beginning balance, value at Dec. 31, 2020 $ 323,182 117,373,818 (121,204,000) (3,507,000)
Balance at beginning, shares at Dec. 31, 2020 323,181,243      
Adjustment for adoption of ASU 2020-06 (60,000) 30,000 (30,000)
Common stock issued on conversion of notes payable $ 15,618 316,382 332,000
Common stock issued on conversion of notes payable, shares 15,617,653      
Warrants issued with convertible notes 156,000 156,000
Fair value of options and warrants issued for services 41,000 41,000
Issuance of shares in private sale of securities $ 8,533 119,467 128,000
Issuance of shares in private sale of securities, shares 8,533,333      
Net loss (1,168,000) (1,168,000)
Ending balance, value at Sep. 30, 2021 $ 347,333 117,946,667 (122,342,000) (4,048,000)
Balance at ending, shares at Sep. 30, 2021 347,332,229      
Beginning balance, value at Jun. 30, 2021 $ 338,111 117,676,889 (121,819,000) (3,804,000)
Balance at beginning, shares at Jun. 30, 2021 338,110,564      
Common stock issued on conversion of notes payable $ 9,222 189,778 199,000
Common stock issued on conversion of notes payable, shares 9,221,665      
Warrants issued with convertible notes 57,000 57,000
Fair value of options and warrants issued for services 23,000 23,000
Issuance of shares in private sale of securities
Net loss (523,000) (523,000)
Ending balance, value at Sep. 30, 2021 $ 347,333 $ 117,946,667 $ (122,342,000) $ (4,048,000)
Balance at ending, shares at Sep. 30, 2021 347,332,229